Open-label Extension Study Of RN624

Completed · Phase 2

Conditions studied: Osteoarthritis, OA Knee Pain, Arthritis

In brief

Study RN624-CL007 is planned to be an open-label protocol to enroll subjects who have previously participated in Study No. RN624-CL006. In this study, subjects will receive RN624 on an open-label basis.

Key facts

Study ID

NCT00399490

Run by

Pfizer

People needed

287

Starts

2006-09-15

Expected to finish

2008-02-11

Last updated by the study team

2021-02-02

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrolled in Study RN624-CL006

You may not qualify if…

• The occurrence of any adverse event or condition during the controlled studies that, in the opinion of the Investigator, should exclude the subject from participating in the open-label extension
• Pregnant or lactating female subjects or subjects who do not agree to use an appropriate form of birth control throughout the study and for 3 months after completing the study

Where it is running

• BrookWood Internal Medicine — Birmingham, Alabama, United States
• Radiant Research — Birmingham, Alabama, United States
• Arizona Research Center, LLC — Phoenix, Arizona, United States
• Imaging Centers of Anaheim — Anaheim, California, United States
• Orange County Clinical Research — Anaheim, California, United States
• Synergy Clinical Research Center — National City, California, United States
• David M. Radin, MD — Stamford, Connecticut, United States
• Stamford Therapeutics Consortium — Stamford, Connecticut, United States
• Covance Clinical Research Unit, Inc — Daytona Beach, Florida, United States
• Ocala Rheumatology Research Center — Ocala, Florida, United States
• Tampa Medical Group, PA — Tampa, Florida, United States
• Habana Hospital Pharmacy — Tampa, Florida, United States
• Covance Clinical Research Unit, Inc. Honolulu — Honolulu, Hawaii, United States
• Covance Boise — Boise, Idaho, United States
• Northwest Indiana Center for Clinical Research — Merrillville, Indiana, United States
• Office of David Neustadt, PSL — Louisville, Kentucky, United States
• The Center for Rheumatology and Bone Research — Wheaton, Maryland, United States
• Clinical Pharmacology Study Group — Worcester, Massachusetts, United States
• Center for Pharmaceutical Research, P.C. — Kansas City, Missouri, United States
• Quality Clincal Research — Omaha, Nebraska, United States
• Albuquerque Clinical Trials — Albuquerque, New Mexico, United States
• AAIR Research Center — Rochester, New York, United States
• Sports Medicine and Orthopaedics Center — Greensboro, North Carolina, United States
• Pharmquest — Greensboro, North Carolina, United States
• Pharmacotherapy Research Associates Incorporated — Zanesville, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.